The bill accelerates development, validation, and public oversight of non‑animal, human‑relevant research methods—potentially improving patient-relevant science and reducing animal use—but it imposes new federal costs, administrative burdens, and transition risks that could slow some research and shift funding priorities.
Scientists and research institutions will get a dedicated NIH center, targeted funding, training, and coordination to develop and validate non‑animal, human‑relevant research methods.
Patients (including those with chronic conditions) could see safer, more effective treatments over time because research would shift toward human‑relevant models (e.g., organoids, in vitro systems) that better predict clinical outcomes.
Federal transparency and standardized reporting of animal use plus required biennial reduction plans will increase public oversight and make it easier to track progress and target funding toward alternatives.
Establishing and operating a new NIH center and related activities will require federal spending and could shift funds away from other research priorities or duplicate existing programs, raising taxpayer costs or forcing trade‑offs.
Researchers and institutions will face new administrative and compliance burdens — exhaustive literature/alternative searches, documentation for grants, biennial reporting and reduction plans — that increase proposal time and institutional costs, with smaller recipients bearing proportionally higher burdens.
Mandated evaluation of all scientifically satisfactory nonanimal methods, requirements for specialized reviewers, and disputed determinations could create reviewer bottlenecks or block/delay some animal studies and regulatory decisions, slowing certain biomedical research projects and potentially delaying patient access to new therapies.
Based on analysis of 5 sections of legislative text.
Creates an NIH center to advance nonanimal research methods, requires NIH to prioritize and verify nonanimal alternatives, and mandates public biennial reporting of animals used in federally funded research.
Official title: To amend the Public Health Service Act to ensure that nonanimal methods are prioritized, where applicable and feasible, in proposals for all research to be conducted or supported by the National Institutes of Health, to provide for the establishment of the National Center for Alternatives to Animals in Research and Testing, and for other purposes.
Introduced February 13, 2025 by Ken Calvert · Last progress February 13, 2025
Creates a new NIH center to accelerate nonanimal, human-relevant research methods and requires NIH and federally funded research entities to prioritize, document, and publicly report alternatives to animal testing. It strengthens NIH review and grant rules to ensure investigators search for and justify why animal use is necessary, and mandates biennial public reporting of counts of animals used or acquired for federally funded research, disaggregated by species, plus plans to reduce those numbers.